MetaCap

CytomX Therapeutics (CTMX) News

NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.03-0.02 (-0.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CTMX news summary

We found 8 recent headlines mentioning CytomX Therapeutics (CTMX): 3 in the past week and 8 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, CTMX is down 0.98% at $2.03. The most recent story, "Regeneron Wins EC Clearance for Libtayo Dosing Flexibility", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest CytomX Therapeutics headlines

Stocks mentioned alongside CTMX

Compare CTMX